The World Anti-Doping Agency (WADA) said it is now monitoring GLP-1 use among elite athletes, including at the Winter Olympics in Italy. Being ‘monitored’ does not mean a substance is prohibited; ...

GLP-1 medications can alter bowel movements, with constipation and diarrhea being the most common side effects. These drugs slow digestion to help control appetite, which can lead to changes in stool ...

The MarketWatch News Department was not involved in the creation of this content. The Federal Trade Commission is sending more than $10.9 million to consumers harmed by a credit repair operation known ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

A new study suggests short-term or interrupted GLP-1 use could put stress on the cardiovascular system and undo hard-won health improvements. A new diabetes study found that three years on a GLP-1 ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. In early March the U.S. Food and Drug Administration sent a warning letter to Novo ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also ...

The benefits of GLP-1 receptor agonists may extend beyond weight management, with results of a large study pointing to their potential role in preventing and treating a wide range of substance use ...

Add Yahoo as a preferred source to see more of our stories on Google. Donald Trump is known for his hasty (and frequent) posts on social media. But in recent months, select posts have concluded with ...

Brianna "Chickenfry" LaPaglia is slamming the use of Ozempic for weight loss. The reality TV star and Barstool Sports personality, 26, got candid about the growing use of GLP-1 weight loss medications ...

Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...